Company Filing History:
Years Active: 2011-2013
Title: Innovator Spotlight: Monika Vastag
Introduction: Monika Vastag, based in Budapest, Hungary, is a prominent inventor known for her significant contributions to the field of pharmaceutical chemistry. With a total of four patents to her name, she has advanced innovative solutions in drug development, particularly in the area of receptor modulation.
Latest Patents: Monika's latest patents include groundbreaking work on benzamide derivatives as bradykinin antagonists. This invention focuses on new phenylsulfamoyl benzamide derivatives aimed at addressing critical medical needs. Additionally, she has developed Thieno[2,3-b]pyridine compounds with mGluR activity. Her work provides not only the compounds themselves but also processes and intermediates for their preparation, pharmaceutical compositions that incorporate these compounds, and insights into their application in treating conditions that necessitate the modulation of mGluR1 and mGluR5 receptors.
Career Highlights: Monika Vastag has made significant strides in her career, with her expertise reflected in her patents and innovative research. She has been associated with Richter Gedeon Nyrt., a leading pharmaceutical company in Hungary, where she has played a pivotal role in various research initiatives.
Collaborations: Throughout her career, Monika has collaborated with notable researchers, including Gyorgy M. Keseru and Amrita Agnes Bobok. These partnerships have enriched her research experience and have contributed to the development of impactful pharmaceutical solutions.
Conclusion: Monika Vastag stands out as a leading figure in her field, with her innovative projects and collaborative efforts highlighting her commitment to advancing pharmaceutical science. Her patents not only reflect her ingenuity but also promise potential breakthroughs in medical treatments, underscoring the importance of innovation in improving healthcare outcomes.